Nucleic acid therapeutics are based on nucleic acids or closely related chemical compounds. They include antisense oligonucleotides, aptamers and small interfering RNAs, and are typically ...
"Nucleic Acid Therapeutics welcomes this fine addition to the armamentarium of bioanalytical assays needed to identify ...
The upcoming Therapeutic Oligonucleotides 2025 conference, hosted by ELRIG, will take place at AstraZeneca’s R&D site in ...
News Medical on MSN9d
ELRIG announces Prof Rory Johnson and Dr Shalini Andersson as keynote speakers at therapeutic oligonucleotides 2025ELRIG, a not-for-profit, volunteer-led organization for the drug discovery community, today announced the keynote speakers for Therapeutic Oligonucleotides 2025 taking place at the AstraZeneca R&D ...
Emergence marks a new beginning for us as a leaner, stronger, well-capitalized company with a mission to revolutionize the way biologic pharmaceuticals are delivered to patients,” said Adi Mohanty, ...
As a hub for next-generation therapeutics, the facility aims to ... effective, and re-dosable nucleic acid delivery technologies. Since its inception in 2016, Entos ® has been dedicated to ...
Exicure, Inc. (NASDAQ:XCUR – Get Free Report) was the recipient of a significant increase in short interest in the month of ...
Codexis shares were 20% higher, at $3.07, after the company recorded its first revenue-generating contract to manufacture siRNA material in its ECO Synthesis Innovation Lab.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback